Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Remimazolam Sedation on Composite Adverse Events in Elderly Patients Undergoing Prostate Biopsy: A Prospective Multicenter Randomized Controlled Trial

NCT07854197 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT07854197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07854197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Remimazolam Sedation on Composite Adverse Events in Elderly Patients Undergoing Prostate Biopsy: A Prospective Multicenter Randomized Controlled Trial
Lead sponsor
RenJi Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 8, 2026
Completion date
July 1, 2027
Enrollment
1,146 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostate biopsy, sedation complication